The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
Bacillus Calmette-Guérin (BCG) remains the cornerstone in the treatment of high-risk non-muscle-invasive bladder cancer (NMIBC), effectively preventing recurrence and progression. Unfortunately, a significant proportion of patients are classified as BCG-unresponsive, and there have been no definite...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Oncology Society
2024-11-01
|
Series: | Journal of Urologic Oncology |
Subjects: | |
Online Access: | http://www.e-juo.org/upload/pdf/juo-244800540047.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|